These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2191158)

  • 1. [Treatment of four cases of B-cell lymphoma].
    Kuroki Y; Tada S; Kitamura T; Kawana N; Ogata K; Idemori M; Inoue S
    Nihon Hifuka Gakkai Zasshi; 1990 Jan; 100(1):71-84. PubMed ID: 2191158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [T-cell lymphomas of the skin: a study of 7 cases excluding mycosis fungoides and adult T-cell leukemia/lymphoma].
    Kuroki Y; Tateyama S; Kurokawa M; Amano M; Kobashi M; Kawana N; Narahara S; Tajiri A; Tada S; Okazaki M
    Nihon Hifuka Gakkai Zasshi; 1989 Oct; 99(11):1173-82. PubMed ID: 2614987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [T-cell lymphoma of the skin--clinicopathological relationships, therapy and survival].
    Nagatani T; Kin S; Baba N; Miyamoto H; Nakajima H
    Nihon Hifuka Gakkai Zasshi; 1989 Apr; 99(5):579-91. PubMed ID: 2585773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment results of tonsillar lymphoma: a 10-year experience.
    Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
    Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cutaneous B-cell lymphoma treatment with rituximab: two cases].
    Viguier M; Bachelez H; Brice P; Rivet J; Dubertret L
    Ann Dermatol Venereol; 2002 Oct; 129(10 Pt 1):1152-5. PubMed ID: 12442128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal lymphoma. A clinicopathologic study with immunophenotypic and genotypic analysis.
    Ferry JA; Sklar J; Zukerberg LR; Harris NL
    Am J Surg Pathol; 1991 Mar; 15(3):268-79. PubMed ID: 1996731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary lymph node involvement from primary cutaneous large B-cell lymphoma of the leg: sentinel lymph nodectomy as a new strategy for staging circumscribed cutaneous lymphomas.
    Starz H; Balda BR; Bachter D; Büchels H; Vogt H
    Cancer; 1999 Jan; 85(1):199-207. PubMed ID: 9921993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary cutaneous large B-cell lymphomas of the legs. A distinct type of cutaneous B-cell lymphoma with an intermediate prognosis. Dutch Cutaneous Lymphoma Working Group.
    Vermeer MH; Geelen FA; van Haselen CW; van Voorst Vader PC; Geerts ML; van Vloten WA; Willemze R
    Arch Dermatol; 1996 Nov; 132(11):1304-8. PubMed ID: 8915307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary breast lymphoma--a report of 27 cases with literature review].
    Cao YB; Wang SS; Huang HQ; Xu GC; He YJ; Guan ZZ; Lin TY
    Ai Zheng; 2007 Jan; 26(1):84-9. PubMed ID: 17222374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Primary centrocytic lymphoma of the skin: diagnosis, course and therapy (author's transl)].
    Schultz-Ehrenburg U; Lämmer D
    Dermatologica; 1981; 162(5):350-61. PubMed ID: 7250469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applying the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome in primary cutaneous marginal zone lymphoma.
    Gerami P; Wickless SC; Rosen S; Kuzel TM; Ciurea A; Havey J; Guitart J
    J Am Acad Dermatol; 2008 Aug; 59(2):245-54. PubMed ID: 18486274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases.
    Grange F; Beylot-Barry M; Courville P; Maubec E; Bagot M; Vergier B; Souteyrand P; Machet L; Dalac S; Esteve E; Templier I; Delaporte E; Avril MF; Robert C; Dalle S; Laroche L; Delaunay M; Joly P; Wechsler J; Petrella T
    Arch Dermatol; 2007 Sep; 143(9):1144-50. PubMed ID: 17875875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-Hodgkin's lymphoma of the paranasal sinuses: clinical and pathological features, and response to combined-modality therapy.
    Hausdorff J; Davis E; Long G; Hoppe R; van der Pas M; Lassman C; Kamel O; Jacobs C
    Cancer J Sci Am; 1997; 3(5):303-11. PubMed ID: 9327155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
    Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Homogeneous clinical behavior of a group of cutaneous B-cell lymphomas].
    de Misa RF; Sastre JL; Azaña JM; Escribano L; Suárez J; Bellas C
    Sangre (Barc); 1995 Dec; 40(6):465-70. PubMed ID: 8850229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difference in prognosis between T- and B-cell lymphomas: clinical study at Shikoku Cancer Center Hospital.
    Toki H; Okabe K; Kimura Y; Yumoto Y; Morita M; Ogushi I; Koike S; Takashima S; Sato G; Moriwaki S
    Jpn J Clin Oncol; 1986 Mar; 16(1):41-8. PubMed ID: 3486301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.
    Guo Y; Lu JJ; Ma X; Wang B; Hong X; Li X; Li J
    Oral Oncol; 2008 Jan; 44(1):23-30. PubMed ID: 17306611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
    Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M
    Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relapse of diffuse large B cell lymphoma to CD20-negative multiple cutaneous tumors immediately after anti-CD20 monoclonal antibody (rituximab) therapy].
    Iguchi T; Miyazawa K; Okabe S; Kawakubo K; Shimamoto T; Kuriyama Y; Ito Y; Kimura Y; Ohyashiki K; Serizawa H; Iwaya K; Mukai K
    Rinsho Ketsueki; 2004 Oct; 45(10):1129-34. PubMed ID: 15553050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.